Sichenzia Ross Ference Carmel LLP Represents Titan Partners Group in $5.55 Million Public Offering of Seelos Therapeutics

Press Release – New York, NY – December 7th, 2023 – Sichenzia Ross Ference Carmel LLP announced on December 1st that it represented Titan Partners Group, (the “Company”), an institutional investor, in a $5.55 million public offering for Seelos Theraputics Inc.’s common stock (NASDAQ: SEEL). They announced that it has priced its underwritten public offering of 1,781,934 shares of its common stock, pre-funded warrants to purchase up to 2,422,612 shares of its common stock, and accompanying common warrants to purchase up to 4,204,546 shares of its common stock.

Each share of common stock and accompanying common warrant to purchase one share of common stock is being sold at a combined price to the public of $1.32 per share of common stock and accompanying common warrant and each pre-funded warrant and accompanying common warrant to purchase one share of common stock is being sold at a combined price to the public of $1.319 per pre-funded warrant and accompanying common warrant. The pre-funded warrants will be immediately exercisable and will have an exercise price of $0.001 per share. The common warrants will be immediately exercisable, will have an exercise price of $1.32 per share, and will expire on the date that is five years following the closing of the offering. All of the shares of common stock, pre-funded warrants, and accompanying common warrants to be sold in the offering are being sold by Seelos.

Seelos Theraputics, Inc. is a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases.

Titan Partners Group, a division of American Capital Partners, is acting as sole book-running manager for the offering.

The Sichenzia Ross Ference Carmel LLP team was led by partner Ross Carmel, Of Counsel Shane Wu, and law clerk Soumya Cheedi.

Click here for a full list of recent transactions headed by SRFC.

• Author
• Recent Posts

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry.  In addition to handling routine to complex commercial matters, SRFC’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations.  The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation.  Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies.  The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA).  These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct.  Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records.  The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.

Visit SRFC's LinkedIn page

Latest posts by Sichenzia Ross Ference Carmel LLP (see all)

• Sichenzia Ross Ference Carmel LLP Represents Bousted Securities, LLC and D. Boral Capital LLC in $3.5 Million Private Placement Offering For Kairos Pharma - January 22, 2025
• Sichenzia Ross Ference Carmel LLP (思成律师事务所/SRFC) 代表 Ribbon Acquisition Corp 完成在纳斯达克交易所5000万美元的首次公开发行 (IPO) - January 15, 2025
• Sichenzia Ross Ference Carmel LLP Represents Craft Capital Management in $600,000 Public Offering of Giftify, Inc. - January 15, 2025